Elevance Health, Inc.
ELV
$411.04
-$11.00-2.61%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 1.06% | 1.45% | 1.51% | 4.91% | 7.40% |
Total Other Revenue | 14.75% | 12.92% | 15.90% | 18.85% | 21.82% |
Total Revenue | 3.19% | 3.20% | 3.62% | 6.89% | 9.41% |
Cost of Revenue | 2.60% | 1.79% | 0.86% | 4.10% | 6.59% |
Gross Profit | 4.75% | 7.00% | 11.33% | 14.89% | 17.65% |
SG&A Expenses | 8.91% | 4.66% | 11.49% | 15.49% | 18.05% |
Depreciation & Amortization | -34.46% | -32.57% | -23.81% | -12.26% | 15.38% |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 3.82% | 2.24% | 2.99% | 6.39% | 9.01% |
Operating Income | -7.00% | 20.59% | 14.28% | 15.42% | 16.42% |
Income Before Tax | 2.45% | 6.96% | 4.23% | 1.54% | 1.51% |
Income Tax Expenses | 12.12% | 10.92% | 0.11% | -0.06% | 0.70% |
Earnings from Continuing Operations | -0.33% | 5.83% | 5.46% | 2.01% | 1.75% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | 325.00% | 170.73% | 140.00% | 142.11% | -166.67% |
Net Income | -0.12% | 7.04% | 6.04% | 2.46% | 1.58% |
EBIT | -7.00% | 20.59% | 14.28% | 15.42% | 16.42% |
EBITDA | -8.97% | 13.56% | 9.19% | 11.29% | 14.41% |
EPS Basic | 1.73% | 9.12% | 8.27% | 4.47% | 3.37% |
Normalized Basic EPS | -7.67% | 25.81% | 17.68% | 18.25% | 17.81% |
EPS Diluted | 1.74% | 9.17% | 8.46% | 4.85% | 3.77% |
Normalized Diluted EPS | -7.71% | 25.96% | 17.99% | 18.80% | 18.39% |
Average Basic Shares Outstanding | -1.85% | -1.91% | -2.00% | -1.93% | -1.83% |
Average Diluted Shares Outstanding | -1.90% | -1.96% | -2.19% | -2.30% | -2.20% |
Dividend Per Share | 10.14% | 11.36% | 12.68% | 14.10% | 15.63% |
Payout Ratio | 0.08% | 0.02% | 0.04% | 0.09% | 0.12% |